J. Jack Lee

The University of Texas of the Permian Basin (US)

Research Areas

Discover Papers by J. Jack Lee

Access 250+ million papers and cite this researcher's work with AI assistance

Try AnswerThis Free →

H-index

146

Publications

2749

Citations

90917

i10-index

951

Publications & Citations Over Time

Top Cited Publications

Want to find and read papers by this researcher? AnswerThis gives you instant access.

Title	Year	Citations
Exosomes facilitate therapeutic targeting of oncog...	2017	2527
<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Res...	2018	1568
Prostate cancer radiation dose response: results o...	2002	1336
Local Consolidative Therapy Vs. Maintenance Therap...	2019	1237
Multi-Institutional Melanoma Lymphatic Mapping Exp...	1999	1149
An Epithelial–Mesenchymal Transition Gene Signatur...	2012	1117
Local consolidative therapy versus maintenance the...	2016	1066
Intratumor heterogeneity in localized lung adenoca...	2014	1002
The BATTLE Trial: Personalizing Therapy for Lung C...	2011	885
Dose Escalation Methods in Phase I Cancer Clinical...	2009	851

Publications

1.
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
Year: 2017Citations: 2527DOI: 10.1038/nature22341
2.
<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung Adenocarcinoma
Year: 2018Citations: 1568DOI: 10.1158/2159-8290.cd-18-0099
3.
Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial
Year: 2002Citations: 1336DOI: 10.1016/s0360-3016(02)02829-8
4.
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study
Year: 2019Citations: 1237DOI: 10.1200/jco.19.00201
5.
Multi-Institutional Melanoma Lymphatic Mapping Experience: The Prognostic Value of Sentinel Lymph Node Status in 612 Stage I or II Melanoma Patients
Year: 1999Citations: 1149DOI: 10.1200/jco.1999.17.3.976
6.
An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance
Year: 2012Citations: 1117DOI: 10.1158/1078-0432.ccr-12-1558
7.
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study
Year: 2016Citations: 1066DOI: 10.1016/s1470-2045(16)30532-0
8.
Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing
Year: 2014Citations: 1002DOI: 10.1126/science.1256930
9.
The BATTLE Trial: Personalizing Therapy for Lung Cancer
Year: 2011Citations: 885DOI: 10.1158/2159-8274.cd-10-0010
10.
Dose Escalation Methods in Phase I Cancer Clinical Trials
Year: 2009Citations: 851DOI: 10.1093/jnci/djp079

About J. Jack Lee

J. Jack Lee is a researcher with 2749 publications and 90917 citations. They are affiliated with The University of Texas of the Permian Basin. Their research focuses on . With an h-index of 146, they are among the top researchers in their field.

Citation Distribution

Distribution of citations across publications

Research Smarter

AnswerThis uses AI to help you search, understand, and cite research from J. Jack Lee and 250M+ other papers.

AI-powered research assistance
Automatic citations and references
Advanced academic writing tools

Research Area Breakdown

Publication Types

Publication type data not available

Impact Metrics Over Time

Citations per publication by year